{"id":"nebcin","rwe":[],"tags":[],"phase":"discontinued","safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Bacterial infection of eye","Dehydration","Diabetes mellitus","Disorder of the 8th Cranial Nerve","Eye infection","Fungal infection of eye","Glaucoma","Herpes simplex dendritic keratitis","Herpes simplex keratitis","Herpes zoster ophthalmicus","Hypocalcemia","Hypomagnesemia","Infant Botulism","Kidney disease","Krukenberg spindle","Myasthenia gravis","Ocular hypertension","Open-angle glaucoma","Parkinsonism","Pregnancy, function","Pseudomembranous enterocolitis","Severe myopia","Tinnitus","Tobramycin Toxicity","Tuberculosis of eye","Vaccinia keratitis","Vertigo","Viral eye infection"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"status":"discontinued","trials":["NCT06383611","NCT02717871","NCT04322500","NCT05313828","NCT04297631","NCT00006280","NCT00198523","NCT02657473","NCT00420836","NCT02208154","NCT06262854","NCT02850029","NCT01559753","NCT00399945","NCT05361941","NCT02038803","NCT00918957","NCT00420628","NCT03875963","NCT00774072","NCT01801774","NCT02015663","NCT00257790","NCT02007174","NCT07072923","NCT06106789","NCT04597008","NCT06404541","NCT02440828","NCT05314673","NCT02035488","NCT03705962","NCT03502070","NCT04213313","NCT02113397","NCT04624035","NCT00699803","NCT05169229","NCT02449031","NCT02873806","NCT01641822","NCT02269969","NCT04571788","NCT00532961","NCT02551796","NCT03464435","NCT01373112","NCT02137161","NCT01775137","NCT02212587"],"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"aiSummary":"","brandName":"Nebcin","companyId":"university-hospital-lille","ecosystem":[],"mechanism":{"target":"Taste receptor type 2 member 20, Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)","novelty":"","modality":"Small molecule","drugClass":"","explanation":"","oneSentence":"","technicalDetail":""},"commercial":null,"references":[],"biosimilars":[],"companyName":"University Hospital, Lille","competitors":[],"dataSources":[{"url":"https://clinicaltrials.gov","name":"ClinicalTrials.gov","fields":["trialDetails","trials"],"retrievedDate":"2026-04-07"},{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"genericName":"Nebcin","indications":{"approved":[{"name":"Allergic conjunctivitis","diseaseId":"allergic-conjunctivitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Anterior uveitis","diseaseId":"anterior-uveitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Bacterial conjunctivitis","diseaseId":"bacterial-conjunctivitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Bacterial infection due to Klebsiella pneumoniae","diseaseId":"bacterial-infection-due-to-klebsiella-pneumoniae","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Bacterial infection due to Serratia","diseaseId":"bacterial-infection-due-to-serratia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Bacterial meningitis","diseaseId":"bacterial-meningitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Bacterial peritonitis","diseaseId":"bacterial-peritonitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Bacterial septicemia","diseaseId":"bacterial-septicemia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Bacterial urinary infection","diseaseId":"bacterial-urinary-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Blepharoconjunctivitis","diseaseId":"blepharoconjunctivitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Citrobacter Complicated UTI","diseaseId":"citrobacter-complicated-uti","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Complicated Proteus UTI","diseaseId":"complicated-proteus-uti","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Complicated UTI with Pseudomonas Aeruginosa","diseaseId":"complicated-uti-with-pseudomonas-aeruginosa","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Complicated Urinary Tract Infections","diseaseId":"complicated-urinary-tract-infections","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Corneal abrasion","diseaseId":"corneal-abrasion","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Dacryocystitis","diseaseId":"dacryocystitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"E. Coli Osteomyelitis","diseaseId":"e.-coli-osteomyelitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"E. Coli Peritonitis","diseaseId":"e.-coli-peritonitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Enterobacter Osteomyelitis","diseaseId":"enterobacter-osteomyelitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Enterobacter Pneumonia","diseaseId":"enterobacter-pneumonia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Escherichia coli urinary tract infection","diseaseId":"escherichia-coli-urinary-tract-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Gram-Negative Aerobic Bacillary Pneumonia","diseaseId":"gram-negative-aerobic-bacillary-pneumonia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Herpes zoster keratitis","diseaseId":"herpes-zoster-keratitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infection due to Enterobacteriaceae","diseaseId":"infection-due-to-enterobacteriaceae","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infection due to Escherichia coli","diseaseId":"infection-due-to-escherichia-coli","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infection due to Staphylococcus aureus","diseaseId":"infection-due-to-staphylococcus-aureus","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infection of bone","diseaseId":"infection-of-bone","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infective blepharitis","diseaseId":"infective-blepharitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Keratoconjunctivitis","diseaseId":"keratoconjunctivitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Klebsiella Pneumoniae Osteomyelitis","diseaseId":"klebsiella-pneumoniae-osteomyelitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Klebsiella Pneumoniae Peritonitis","diseaseId":"klebsiella-pneumoniae-peritonitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Meibomianitis","diseaseId":"meibomianitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Neonatal meningitis","diseaseId":"neonatal-meningitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Nosocomial pneumonia","diseaseId":"nosocomial-pneumonia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Osteomyelitis due to Staphylococcus aureus","diseaseId":"osteomyelitis-due-to-staphylococcus-aureus","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Perforation of cornea","diseaseId":"perforation-of-cornea","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pneumonia due to Escherichia coli","diseaseId":"pneumonia-due-to-escherichia-coli","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pneumonia due to Pseudomonas","diseaseId":"pneumonia-due-to-pseudomonas","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Proteus Mirabilis Osteomyelitis","diseaseId":"proteus-mirabilis-osteomyelitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Providencia Complicated UTI","diseaseId":"providencia-complicated-uti","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pseudomonas Aeruginosa Osteomyelitis","diseaseId":"pseudomonas-aeruginosa-osteomyelitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Punctate keratitis","diseaseId":"punctate-keratitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Rhinoscleroma","diseaseId":"rhinoscleroma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Rosacea","diseaseId":"rosacea","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Sepsis due to Pseudomonas","diseaseId":"sepsis-due-to-pseudomonas","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Sepsis of the newborn","diseaseId":"sepsis-of-the-newborn","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Septicemia due to Escherichia coli","diseaseId":"septicemia-due-to-escherichia-coli","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Serratia Complicated UTI","diseaseId":"serratia-complicated-uti","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Skin and Skin Structure Proteus Infection","diseaseId":"skin-and-skin-structure-proteus-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Skin and Skin Structure Pseudomonas Aeruginosa Infection","diseaseId":"skin-and-skin-structure-pseudomonas-aeruginosa-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Staphylococcal pneumonia","diseaseId":"staphylococcal-pneumonia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Staphylococcus Aureus Complicated UTI","diseaseId":"staphylococcus-aureus-complicated-uti","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Synergy for Bacterial Meningitis","diseaseId":"synergy-for-bacterial-meningitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Synergy for Neonatal Meningitis","diseaseId":"synergy-for-neonatal-meningitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Synergy for Nosocomial Pneumonia due to Pseudomonas Aeruginosa","diseaseId":"synergy-for-nosocomial-pneumonia-due-to-pseudomonas-aeruginosa","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Synergy for P. Aeruginosa Infection in Cystic Fibrosis","diseaseId":"synergy-for-p.-aeruginosa-infection-in-cystic-fibrosis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Synergy for Staphylococcal Infections","diseaseId":"synergy-for-staphylococcal-infections","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Urinary tract infection caused by Klebsiella","diseaseId":"urinary-tract-infection-caused-by-klebsiella","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Uveitis","diseaseId":"uveitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06383611","phase":"N/A","title":"Protocol for Expanded Access to Cyclic Irrigation of Vancomycin Hydrochloride and Tobramycin Sulfate in Patients Undergoing Exchange Arthroplasty for Periprosthetic Joint Infection of the Hip or Knee","status":"TEMPORARILY_NOT_AVAILABLE","sponsor":"Osteal Therapeutics, Inc.","isPivotal":false,"enrollment":0,"indication":"Prosthetic-joint Infection","completionDate":""},{"nctId":"NCT02717871","phase":"Phase 3","title":"Swiss PACK-CXL (Photoactivated Chromophore for Infectious Keratitis Cross-linking) Multicenter Trial for the Treatment of Infectious Keratitis","status":"COMPLETED","sponsor":"University Hospital, Geneva","isPivotal":true,"enrollment":35,"indication":"Keratitis; Infectious Disease (Manifestation)","completionDate":"2020-10"},{"nctId":"NCT04322500","phase":"NA","title":"Intestinal Microbiota: a New Target for Chalaziosis Treatment in Children","status":"COMPLETED","sponsor":"University of Molise","isPivotal":false,"enrollment":26,"indication":"Chalazion","completionDate":"2020-02-29"},{"nctId":"NCT05313828","phase":"N/A","title":"Effect of Various Treatment Modalities on Dendritic Vial Ulcer","status":"UNKNOWN","sponsor":"Sohag University","isPivotal":false,"enrollment":40,"indication":"Corneal Ulcer","completionDate":"2022-07-20"},{"nctId":"NCT04297631","phase":"Phase 4","title":"Prospective Study Investigating Antibiotic Elution From Free Intra-articular Vancomycin and Tobramycin After Cementless Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Washington University School of Medicine","isPivotal":false,"enrollment":20,"indication":"Antibotics in Cementless Knees","completionDate":"2020-11-01"},{"nctId":"NCT00006280","phase":"Phase 2","title":"A Phase II Multicenter Randomized Trial of Tobramycin for Inhalation in Young Children With Cystic Fibrosis","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","isPivotal":false,"enrollment":98,"indication":"Cystic Fibrosis","completionDate":"2002-02"},{"nctId":"NCT00198523","phase":"Phase 3","title":"A Multi-Center, Randomized, Double Masked, Bioequivalence Study of Tobramycin and Prednisolone Acetate (0.3/1.0%, ISTA) Ophthalmic Suspension Compared to PredForte (1.0% Prednisolone Acetate, Allergan","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","isPivotal":true,"enrollment":132,"indication":"Eye Infections, Postoperative Complications","completionDate":"2005-10"},{"nctId":"NCT02657473","phase":"Phase 2","title":"Long-term Inhaled Nebulized Tobramycin in Patients With Non-cystic Fibrosis Bronchiectasis. A Randomized Placebo Controlled Trial. The BATTLE Study Bronchiectasis And Tobramycin SoluTion InhaLation Th","status":"COMPLETED","sponsor":"Medical Center Alkmaar","isPivotal":true,"enrollment":58,"indication":"Non-CF Bronchiectasis","completionDate":"2019-12-13"},{"nctId":"NCT00420836","phase":"Phase 1","title":"Crossover Pharmacokinetic Study of Tobramycin Administered for Inhalation by PARI eFlow® Rapid Electronic Nebulizer (no Compressor) vs. PARI LC PLUSTM Jet Nebulizer (With Compressor) in Cystic Fibrosi","status":"COMPLETED","sponsor":"Novartis","isPivotal":false,"enrollment":20,"indication":"Cystic Fibrosis","completionDate":""},{"nctId":"NCT02208154","phase":"Phase 3","title":"RGNOSIS: Ecological Effects of Decolonisation Strategies in Intensive Care","status":"COMPLETED","sponsor":"MJM Bonten","isPivotal":true,"enrollment":8665,"indication":"ICU-ecology (Multidrug Resistant Bacteria), ICU-acquired Bacteraemia","completionDate":"2017-10-27"},{"nctId":"NCT06262854","phase":"NA","title":"Efficacy and Safety of aBIo- Absorbable Antibiotic Delivery in Calcium Sulphate Granules (Stimulan®) for the Treatment of Osteomyelitis in Patients With Diabetic FOOT: a Randomised, Double Blind, Cont","status":"UNKNOWN","sponsor":"Azienda Ospedaliero-Universitaria Careggi","isPivotal":false,"enrollment":50,"indication":"Diabete Mellitus, Foot Ulcer","completionDate":"2025-05-31"},{"nctId":"NCT02850029","phase":"N/A","title":"An International Survey on Aminoglycoside Practices in Critically Ill Patients: AMINO III Survey","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nīmes","isPivotal":false,"enrollment":964,"indication":"Underdosing of Aminoglycosides, Critical Illness","completionDate":"2017-12-31"},{"nctId":"NCT01559753","phase":"Phase 4","title":"Comparison of Two Lengths of Treatment in Early-onset Ventilated Associated Pneumonia","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Besancon","isPivotal":false,"enrollment":225,"indication":"Pneumonia Ventilator Associated","completionDate":"2002-11"},{"nctId":"NCT00399945","phase":"Phase 1","title":"A Phase 1, Single-Dose, Open-Label, Two-Way Crossover, Pharmacoscintigraphy Study of Aerosol Delivery Characteristics (Measured by In Vivo Lung Deposition, Nebulization Time, Serum Tobramycin Concentr","status":"COMPLETED","sponsor":"Novartis","isPivotal":false,"enrollment":12,"indication":"Cystic Fibrosis","completionDate":""},{"nctId":"NCT05361941","phase":"NA","title":"Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth In/near Infected Bone Cavities","status":"RECRUITING","sponsor":"Elute, Inc.","isPivotal":false,"enrollment":204,"indication":"Periprosthetic Joint Infections","completionDate":"2025-12-31"},{"nctId":"NCT02038803","phase":"N/A","title":"Patient Preferences and Efficacy of TOBI Podhaler vs. Tobramycin Inhalation Solution (PETIS)","status":"TERMINATED","sponsor":"Rush University Medical Center","isPivotal":false,"enrollment":5,"indication":"Cystic Fibrosis","completionDate":"2014-05-07"},{"nctId":"NCT00918957","phase":"Phase 3","title":"A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase III Study in Cystic Fibrosis (CF) Subjects to Assess Efficacy, Safety and Pharmacokinetics of Tobramycin Inhalation Powder From a Mod","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","isPivotal":true,"enrollment":62,"indication":"Cystic Fibrosis","completionDate":"2011-05"},{"nctId":"NCT00420628","phase":"Phase 4","title":"A Safety and Efficacy Study of Zylet® (Loteprednol Etabonate 0.5% and Tobramycin 0.3% Ophthalmic Suspension) Compared to Vehicle in the Management of Lid Inflammation (Chalazion/Hordeolum) in Pediatri","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","isPivotal":false,"enrollment":108,"indication":"Chalazion, Hordeolum","completionDate":"2009-06"},{"nctId":"NCT03875963","phase":"NA","title":"Performance of Antibiotic Impregnated Calcium Sulfate: A Prospective Randomized Controlled Trial","status":"TERMINATED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","isPivotal":false,"enrollment":100,"indication":"Fracture Non Union, Infection","completionDate":"2022-11-23"},{"nctId":"NCT00774072","phase":"Phase 2","title":"Nasal Inhalation of Tobramycin by the Pari Sinus Nebulizer in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Colonization in the Upper Airways","status":"COMPLETED","sponsor":"University of Jena","isPivotal":false,"enrollment":9,"indication":"Cystic Fibrosis, Pseudomonas Aeruginosa","completionDate":"2010-11"},{"nctId":"NCT01801774","phase":"Phase 4","title":"Quantitative Comparison of the Efficacy of Subtenon 20-mg Triamcinolone Injection With 0.1% Dexamethasone Eye Drop in Controlling Intraocular Inflammation After Phacoemulsification","status":"UNKNOWN","sponsor":"Mahidol University","isPivotal":false,"enrollment":140,"indication":"Inflammation, Intraocular Pressure","completionDate":"2015-07"},{"nctId":"NCT02015663","phase":"Phase 4","title":"A 24-week, Open-label, Parallel-group, Interventional Phase IV Study Comparing Tobramycin Inhalation Powder (TIP) Administered Once Daily Continuously Versus TIP Administered BID in 28 Day on / 28 Day","status":"TERMINATED","sponsor":"Novartis Pharmaceuticals","isPivotal":false,"enrollment":32,"indication":"Cystic Fibrosis","completionDate":"2014-12"},{"nctId":"NCT00257790","phase":"Phase 4","title":"Tobramycin én Gang Daglig Mot Tre Ganger Daglig, Gitt Med Benzylpenicillin, Til Pasienter Med nøytropen Feber","status":"COMPLETED","sponsor":"Oslo University Hospital","isPivotal":false,"enrollment":210,"indication":"Neutropenia, Fever","completionDate":"2005-03"},{"nctId":"NCT02007174","phase":"N/A","title":"Triple Subconjunctival Bevacizumab Injection for Early Recurrent Pterygium. One Year Follow-up","status":"COMPLETED","sponsor":"Instituto de Oftalmología Fundación Conde de Valenciana","isPivotal":false,"enrollment":38,"indication":"Recurrent Pterygium","completionDate":"2013-08"},{"nctId":"NCT07072923","phase":"Phase 4","title":"Utility of Antibiotic Impregnated Beads in Lower Extremity Osteomyelitis","status":"NOT_YET_RECRUITING","sponsor":"University of Arizona","isPivotal":false,"enrollment":100,"indication":"Osteomyelitis of the Foot, Antibiotic Impregnated Beads","completionDate":"2027-09-30"},{"nctId":"NCT06106789","phase":"N/A","title":"A Study of the Clinical Benefit of Tobramycin Inhalation Solution","status":"ACTIVE_NOT_RECRUITING","sponsor":"Qianfoshan Hospital","isPivotal":false,"enrollment":1600,"indication":"Bronchiectasis, Cystic Fibrosis","completionDate":"2024-10-30"},{"nctId":"NCT04597008","phase":"Phase 3","title":"Topical Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: TOBRA - A Multicenter Randomized Controlled Trial","status":"COMPLETED","sponsor":"Major Extremity Trauma Research Consortium","isPivotal":true,"enrollment":1550,"indication":"Post Operative Surgical Site Infection","completionDate":"2025-07-30"},{"nctId":"NCT06404541","phase":"Phase 4","title":"A Comparison Between the Ocular Surface of Different Concentrations of Benzalkonium Chloride Preservative in Postoperative Topical Medications After Cataract Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kasr El Aini Hospital","isPivotal":false,"enrollment":60,"indication":"Ocular Surface Disease, Dry Eye Syndromes","completionDate":"2024-05"},{"nctId":"NCT02440828","phase":"Phase 4","title":"Ventilator Associated Pneumonia: Addition of Tobramycin Inhalation Antibiotic Treatment to Standard IV Antibiotic Treatment","status":"COMPLETED","sponsor":"Erasmus Medical Center","isPivotal":false,"enrollment":80,"indication":"Ventilator Associated Pneumonia (VAP)","completionDate":"2020-07-01"},{"nctId":"NCT05314673","phase":"Phase 4","title":"Preoperative Intra-lesional Bevacizumab Injection in Primary Pterygium in Tunisian Patients: A Randomized Controlled Prospective Study","status":"COMPLETED","sponsor":"University Hospital Fattouma Bourguiba","isPivotal":false,"enrollment":60,"indication":"Pterygium","completionDate":"2021-01-01"},{"nctId":"NCT02035488","phase":"Phase 1","title":"Pharmacokinetic Evaluation and Tolerability of Dry Powder Tobramycin by a Novel Device in Patients With Non Cystic Fibrosis Bronchiectasis","status":"COMPLETED","sponsor":"University Medical Center Groningen","isPivotal":false,"enrollment":8,"indication":"Bronchiectasis","completionDate":"2014-12"},{"nctId":"NCT03705962","phase":"Phase 3","title":"Locally Applied Antibiotics for Infection Prophylaxis in Treatment of Open Fractures","status":"TERMINATED","sponsor":"University of Virginia","isPivotal":true,"enrollment":11,"indication":"Fractures, Open","completionDate":"2019-03-07"},{"nctId":"NCT03502070","phase":"Phase 4","title":"A Multicenter, Human Factors Validation Study in Cystic Fibrosis Patients Aged 6 Years and Older to Evaluate the User Interface of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules","status":"COMPLETED","sponsor":"Mylan Inc.","isPivotal":false,"enrollment":47,"indication":"Cystic Fibrosis","completionDate":"2019-06-17"},{"nctId":"NCT04213313","phase":"N/A","title":"Consecutive, Case Control Study of Association Between Single Nucleotide Polymorphism of SP-D and Susceptibility and Prognosis of Infectious Keratitis","status":"COMPLETED","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","isPivotal":false,"enrollment":145,"indication":"Infectious Keratitis","completionDate":"2019-06-30"},{"nctId":"NCT02113397","phase":"N/A","title":"Comparative Evaluation of Bacterial Diversity and Richness in CF Lung in Patients Who Use Cycled Every Other Month Tobramycin Inhalation Powder (TOBI™ Podhaler™) Or Continuous Alternating Therapy With","status":"TERMINATED","sponsor":"Dartmouth-Hitchcock Medical Center","isPivotal":false,"enrollment":1,"indication":"Cystic Fibrosis","completionDate":"2016-08"},{"nctId":"NCT04624035","phase":"NA","title":"Comparison Between Implantable Phakic Intraocular Lens and Implantable Collamer Lens in Treatment of Myopia in Adults","status":"UNKNOWN","sponsor":"Assiut University","isPivotal":false,"enrollment":60,"indication":"Myopia","completionDate":"2021-10"},{"nctId":"NCT00699803","phase":"Phase 2","title":"","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","isPivotal":false,"enrollment":64,"indication":"Cataract","completionDate":"2008-08"},{"nctId":"NCT05169229","phase":"Phase 2","title":"Antibiotic Impregnated Bone Graft to Reduce Infection in Hip Replacement. The ABOGRAFT Trial","status":"RECRUITING","sponsor":"University Hospital, Linkoeping","isPivotal":true,"enrollment":1100,"indication":"Arthroplasty, Replacement, Hip, Osteoarthritis, Hip","completionDate":"2031-12"},{"nctId":"NCT02449031","phase":"N/A","title":"A Prospective Observational Study in Cystic Fibrosis Patients With Chronic Respiratory Pseudomonas Aeruginosa Infection Treated With TOBI® PODHALER® (Tobramycin Inhalation Powder) or Other FDA Approve","status":"COMPLETED","sponsor":"Mylan Inc.","isPivotal":false,"enrollment":409,"indication":"Pseudomonas Aeruginosa in Cystic Fibrosis","completionDate":"2021-12-31"},{"nctId":"NCT02873806","phase":"Phase 4","title":"A Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medications (One a Prostaglandin) Treated With Two Trabecular Micro-bypass Stents (iStent Inject) and a Postoperativ","status":"COMPLETED","sponsor":"Glaukos Corporation","isPivotal":false,"enrollment":53,"indication":"Open-angle Glaucoma","completionDate":"2019-11-08"},{"nctId":"NCT01641822","phase":"Phase 3","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy (CAT) Regimen of Inhaled Antibiotics for the ","status":"COMPLETED","sponsor":"Gilead Sciences","isPivotal":true,"enrollment":107,"indication":"Cystic Fibrosis","completionDate":"2015-01"},{"nctId":"NCT02269969","phase":"Phase 1","title":"Once Daily Aminoglycoside Pharmacokinetics and Optimal Dosing in the Burn Population: A Prospective Study","status":"COMPLETED","sponsor":"Sandra Walker","isPivotal":false,"enrollment":10,"indication":"Burns, Infection","completionDate":"2015-12"},{"nctId":"NCT04571788","phase":"N/A","title":"Treating Rhegmatogenous Retinal Detachment by Foldable Capsular Buckle (FCB): a Randomized, Controlled, Single-blind and Multicenter Study","status":"UNKNOWN","sponsor":"Aier School of Ophthalmology, Central South University","isPivotal":false,"enrollment":150,"indication":"Rhegmatogenous Retinal Detachment, Surgery","completionDate":"2021-12-01"},{"nctId":"NCT00532961","phase":"Phase 4","title":"A Randomized, Double-masked, Parallel Comparison of Ocular Tolerance and IOP Effects of Zylet vs TobraDex Administered Four Times Daily for Four Weeks in Healthy Volunteers","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","isPivotal":false,"enrollment":310,"indication":"Inflammation","completionDate":"2005-06"},{"nctId":"NCT02551796","phase":"NA","title":"Comparison of Early Changes in Ocular Surface and Inflammatory Mediators Among Lenticule Extraction, Laser in Situ Keratomileusis and Femtosecond Laser-assisted Laser in Situ Keratomileusis","status":"COMPLETED","sponsor":"Sun Yat-sen University","isPivotal":false,"enrollment":75,"indication":"Myopia, Astigmatism","completionDate":"2016-04"},{"nctId":"NCT03464435","phase":"Phase 4","title":"A Novel Combined Therapy for Refractory Vernal Keratoconjunctivitis","status":"COMPLETED","sponsor":"Zhongshan Ophthalmic Center, Sun Yat-sen University","isPivotal":false,"enrollment":20,"indication":"Vernal Keratoconjunctivitis","completionDate":"2018-02-01"},{"nctId":"NCT01373112","phase":"NA","title":"Articulating Versus Static Antibiotic Loaded Spacers for the Treatment of Prosthetic Knee Infection","status":"COMPLETED","sponsor":"Rush University Medical Center","isPivotal":false,"enrollment":68,"indication":"Osteoarthritis, Knee Infection","completionDate":"2020-08"},{"nctId":"NCT02137161","phase":"Phase 4","title":"The Reggio Emilia Study on Bromfenac for Patients With PseudoEXfoliation Syndrome Undergoing Cataract Surgery: the REPEX Study","status":"COMPLETED","sponsor":"Azienda USL Reggio Emilia - IRCCS","isPivotal":false,"enrollment":62,"indication":"Cataract, Pseudoexfoliation Syndrome","completionDate":"2014-10"},{"nctId":"NCT01775137","phase":"Phase 4","title":"A 48 Week Extension to CTBM100C2401, a Single Arm, Open-label, Multicenter, Phase IV Extension Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis W","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","isPivotal":false,"enrollment":45,"indication":"Long-term Safety of TIP","completionDate":"2014-11"},{"nctId":"NCT02212587","phase":"Phase 1","title":"Pilot Study of the in Vivo Efficacy of Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Patients Infected With Burkholderia Cepacia Complex","status":"COMPLETED","sponsor":"Unity Health Toronto","isPivotal":false,"enrollment":10,"indication":"Cystic Fibrosis, Burkholderia Cepacia Infection","completionDate":"2016-05"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"icon":"","route":"","frequency":"","formulation":""},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[],"therapeuticAreas":["Infectious Disease"],"biosimilarFilings":[],"firstApprovalDate":"","companionDiagnostics":[],"firstApprovalCountry":null,"genericManufacturerList":[],"modality":"Small molecule","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}